Company Filing History:
Years Active: 2007-2015
Title: Sato Aihara: Innovator in Nucleic Acid Constructs and Cyclic Depsipeptide Synthesis
Introduction
Sato Aihara is a notable inventor based in Odawara, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of nucleic acid constructs and cyclic depsipeptide synthetases. With a total of two patents to his name, Aihara's work is paving the way for advancements in the production of valuable compounds.
Latest Patents
Aihara's latest patents include a nucleic acid construct comprising a pyripyropene biosynthetic gene cluster and a marker gene. This invention provides an inexpensive and highly productive method for producing pyripyropene. Another significant patent is for a cyclic depsipeptide synthetase and method for recombinant production. This invention offers an enzyme that synthesizes a cyclic depsipeptide, particularly the substance 1022, along with a gene that encodes this enzyme. The cyclic depsipeptide synthetase gene comprises a nucleotide sequence that enables the production of the cyclic depsipeptide synthetase, along with a recombinant vector and a transformant for expressing the enzyme.
Career Highlights
Throughout his career, Aihara has worked with prominent companies such as Meiji Seika Kaisha, Ltd. and Meiji Seika Pharma Co., Ltd. His experience in these organizations has contributed to his expertise in biotechnology and innovation.
Collaborations
Aihara has collaborated with notable coworkers, including Naoki Midoh and Kaoru Okakura, who is a talented woman in the field. These collaborations have likely enriched his research and development efforts.
Conclusion
Sato Aihara's innovative work in nucleic acid constructs and cyclic depsipeptide synthesis showcases his significant contributions to biotechnology. His patents reflect a commitment to advancing methods for producing valuable compounds, which may have far-reaching implications in various industries.